Actonel (risedronate) is now approved for osteoporosis
Actonel (risedronate) is now approved for osteoporosis.
Actonel is a bisphosphonate...similar to Fosamax (alendronate). But until now, Actonel was approved only for Paget's disease.
The new indication is to prevent or treat osteoporosis in postmenopausal women...or in patients taking glucocorticoids.
Practical advice for a better career, with unlimited access to CE
Pharmacy Technician's Letter includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 120+ CE courses, including the popular CE-in-the-Letter
- Helpful, in-depth Technician Tutorials
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote